NCT07699809 Administration of a 'Thirst Relieve Kit' Versus Placebo in Patients After Hospital-based Bowel Preparation for Colonoscopy and Assessment of Thirst Intensity
| NCT ID | NCT07699809 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Sirio-Libanes |
| Condition | Thirst |
| Study Type | INTERVENTIONAL |
| Enrollment | 158 participants |
| Start Date | 2025-12-08 |
| Primary Completion | 2026-08-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 158 participants in total. It began in 2025-12-08 with a primary completion date of 2026-08-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate whether a "thirst kit" (lemon popsicle) is effective in reducing thirst intensity in patients undergoing hospital bowel preparation for colonoscopy. The study also aims to assess the impact of the thirst kit on associated symptoms and patient satisfaction. The main questions it aims to answer are: * Does the thirst kit reduce the intensity of thirst after bowel preparation for colonoscopy? * Does the thirst kit reduce symptoms such as dry mouth and dry throat? * How satisfied are patients when using the thirst kit compared to a placebo? Researchers will compare the thirst kit to a placebo to determine its effectiveness in managing thirst during the pre-colonoscopy period. Participants will: * Be randomly assigned to receive either the thirst kit (lemon popsicle) or a placebo * Use the assigned intervention during the hospital preparation period for colonoscopy * Rate thirst intensity, associated symptoms, and satisfaction using numerical scales
Eligibility Criteria
Inclusion Criteria: * both sexes * aged 18 years or older, with clear awareness and good cooperation * who underwent colonoscopy with hospital bowel preparation Exclusion Criteria: * any risk of oral fluid aspiration * swallowing disorders * post-operative advanced head and neck surgeries * advanced head and neck neoplasia, active oral diseases (oral mucosal lesions, stomatitis, among others) * history of gastric surgeries (gastrectomized, upper gastrointestinal tract surgeries for obesity) * use of GLP-1 analog medications and derivatives in the last 10 days according to hospital protocol (e.g., semaglutide, liraglutide, dulaglutide, tirzepatide...) * history of dementia.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07699809 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thirst. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07699809 currently recruiting?
Yes, NCT07699809 is actively recruiting participants. Contact the research team at carlos.frederico@hc.fm.usp.br for enrollment information.
Where is the NCT07699809 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT07699809 clinical trial?
NCT07699809 is sponsored by Hospital Sirio-Libanes. The trial plans to enroll 158 participants.